227
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Trimethylamine N-Oxide and Related Metabolites in the Serum and Risk of Type 2 Diabetes in the Chinese Population: A Case-Control Study

ORCID Icon, , , , &
Pages 547-555 | Received 17 Nov 2022, Accepted 14 Feb 2023, Published online: 27 Feb 2023

References

  • Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-6
  • Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–2251. doi:10.1016/S0140-6736(17)30058-2
  • Ke P, Wu X, Xu M, et al. Comparison of obesity indices and triglyceride glucose-related parameters to predict type 2 diabetes mellitus among normal-weight elderly in China. Eat Weight Disord. 2022;27(3):1181–1191. doi:10.1007/s40519-021-01238-w
  • Federation ID. IDF Diabetes Atlas. 10th ed. International Diabetes Federation Diabetes Atlas; 2021:1–135.
  • Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9(6):767–780. doi:10.1111/j.1463-1326.2006.00655.x
  • Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl):S35–42. doi:10.1016/j.jacc.2008.09.055
  • Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80. doi:10.1016/S2213-8587(17)30186-9
  • McEntyre CJ, Lever M, Chambers ST, et al. Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann Clin Biochem. 2015;52(Pt 3):352–360. doi:10.1177/0004563214545346
  • Fennema D, Phillips IR, Shephard EA. Trimethylamine and Trimethylamine N-Oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease. Drug Metab Dispos. 2016;44(11):1839–1850. doi:10.1124/dmd.116.070615
  • Chen S, Henderson A, Petriello MC, et al. Trimethylamine N-Oxide binds and activates PERK to promote metabolic dysfunction. Cell Metab. 2019;30(6):1141–1151 e5. doi:10.1016/j.cmet.2019.08.021
  • Lemaitre RN, Jensen PN, Wang Z, et al. Association of trimethylamine N -Oxide and related metabolites in plasma and incident type 2 diabetes. JAMA Netw Open. 2021;4(8):e2122844. doi:10.1001/jamanetworkopen.2021.22844
  • Garcia E, Oste MCJ, Bennett DW, et al. High betaine, a Trimethylamine N-Oxide related metabolite, is prospectively associated with low future risk of type 2 diabetes mellitus in the PREVEND study. J Clin Med Nov. 2019;8(11). doi:10.3390/jcm8111813
  • Zhuang R, Ge X, Han L, et al. Gut microbe–generated metabolite trimethylamine N -oxide and the risk of diabetes: a systematic review and dose-response meta-analysis. Obes Rev. 2019;20(6):883–894. doi:10.1111/obr.12843
  • Dibaba DT, Johnson KC, Kucharska-Newton AM, Meyer K, Zeisel SH, Bidulescu A. The association of dietary choline and betaine with the risk of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2020;43(11):2840–2846. doi:10.2337/dc20-0733
  • Du Y, Ding L, Na L, et al. Prevalence of chronic diseases and alterations of gut microbiome in people of Ningxia china during urbanization: an epidemiological survey. Front Cell Infect Microbiol. 2021;11:707402. doi:10.3389/fcimb.2021.707402
  • Wang Z, Levison BS, Hazen JE, Donahue L, Li X-M, Hazen SL. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 2014;455:35–40. doi:10.1016/j.ab.2014.03.016
  • Shan Z, Sun T, Huang H, et al. Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes. Am J Clin Nutr. 2017;106(3):888–894. doi:10.3945/ajcn.117.157107
  • Tang WH, Wang Z, Li XS, et al. Increased Trimethylamine N-Oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clin Chem. 2017;63(1):297–306. doi:10.1373/clinchem.2016.263640
  • Heianza Y, Sun D, Smith SR, Bray GA, Sacks FM, Qi L. Changes in gut Microbiota–related metabolites and long-term successful weight loss in response to weight-loss diets: the POUNDS lost trial. Diabetes Care. 2018;41(3):413–419. doi:10.2337/dc17-2108
  • Papandreou C, Bullo M, Zheng Y, et al. Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial. Am J Clin Nutr. 2018;108(1):163–173. doi:10.1093/ajcn/nqy058
  • Huo X, Li J, Cao Y-F, et al. Trimethylamine N-Oxide metabolites in early pregnancy and risk of gestational diabetes: a nested case-control study. J Clin Endocrinol Metab. 2019;104(11):5529–5539. doi:10.1210/jc.2019-00710
  • Kalagi NA, Thota RN, Stojanovski E, Alburikan KA, Garg ML. Association between Plasma Trimethylamine N-Oxide Levels and Type 2 Diabetes: a Case Control Study. Nutrients. 2022;14(10):2093. doi:10.3390/nu14102093
  • Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 2003;133(5):1302–1307. doi:10.1093/jn/133.5.1302
  • Zeisel SH, Klatt KC, Caudill MA. Choline. Adv Nutr. 2018;9(1):58–60. doi:10.1093/advances/nmx004
  • Feller AG, Rudman D. Role of carnitine in human nutrition. J Nutr. 1988;118(5):541–547. doi:10.1093/jn/118.5.541
  • Zhu Y, Jameson E, Crosatti M, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111(11):4268–4273. doi:10.1073/pnas.1316569111
  • Lang DH, Yeung CK, Peter RM, et al. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol. 1998;56(8):1005–1012. doi:10.1016/s0006-2952(98)00218-4
  • Flores-Guerrero JL, van Dijk PR, Connelly MA, et al. Circulating Trimethylamine N-Oxide is associated with increased risk of cardiovascular mortality in type-2 diabetes: results from a Dutch Diabetes Cohort (ZODIAC-59). J Clin Med. 2021;10(11). doi:10.3390/jcm10112269
  • Cardona A, O’Brien A, Bernier MC, et al. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis. BMJ Open Diabetes Res Care. 2019;7(1):e000718. doi:10.1136/bmjdrc-2019-000718